Headlands Technologies »

Fate Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.9k 532 7.34

More positions owned by Headlands Technologies

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Linde SHS (LIN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vale S A Sponsored Ads (VALE)
Asml Holding N V N Y Registry Shs (ASML)
Rio Tinto Sponsored Adr (RIO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Applied Materials (AMAT)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Broadcom (AVGO)
At&t (T)
Verisign (VRSN)

View all positions for Headlands Technologies

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
Boxer Capital
Bellevue Group
Johnson & Johnson
Citadel Advisors
Morgan Stanley
D. E. Shaw & Co
Suvretta Capital Management
Assenagon Asset Management
Holocene Advisors
Deerfield Management Company
Adage Capital Partners GP
Goldman Sachs Group

View all funds holding Fate Therapeutics